MENU
BCDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCardia (BCDA) Ownership - Who owns BioCardia?
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs... Show more
Profile
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.65M
P/E Ratio
N/A
Total Cash
949K
Projected Growth
N/A
Total Debt
850K
Revenue
3K
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
0.18
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
BCDA
Capitalization
11.7M
P/E Ratio
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
949K
Total Cash/Share
0.18
Total Debt
850K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
3K
ROE
N/A
Book Value
-1.52M
P/B Ratio
13.64
Cash Flow
N/A
Earnings
-2.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
0.36
Current Revenue Per Employee
150.00
Dividends Per Share - Security
N/A
EBITDA
-8.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-346.38
Shares Held By Institutions
632K
Shares Outstanding - Current
5.18M
Total Liabilities
3.69M
Total Volume MTD
N/A
Value
-1
Gain YTD
3.211
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage regenerative medicine company, which develops novel therapeutics for cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com